Position in PGEN
as of Mar 31, 2026
· filed May 11, 2026
Position Value
$781,595
-$582,555 QoQ
Shares Held
201,963
-38.1% QoQ
Ownership
0.057%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 98%
Shared 0%
None 2%
Common Shares in PGEN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026WELLS FARGO & COMPANY/MN holds $1,292,861,286 across 390 Biotechnology names. PGEN ranks #107 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
744,995 | $332,670,066 | |
| 2 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
342,763 | $113,409,991 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
142,021 | $109,731,102 | |
| 4 | HALO |
Halozyme Therapeutics, Inc.
|
1,535,737 | $99,254,679 | |
| 5 | INSM |
INSMED Inc
|
597,384 | $97,684,229 | |
| 6 | ASND |
Ascendis Pharma A/S
|
154,199 | $35,269,936 | |
| 7 | EXEL |
Exelixis, Inc.
|
687,304 | $29,478,466 | |
| 8 | ARGX |
Argenx SE
|
38,104 | $27,825,444 |
All Filings in PGEN
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $781,595 | 201,963 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $1,364,150 | 326,352 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $637,798 | 193,860 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $228,092 | 160,629 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $218,218 | 146,456 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $128,304 | 114,558 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $97,158 | 102,273 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $165,178 | 104,544 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $140,983 | 97,231 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $132,108 | 98,589 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $128,599 | 90,564 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $120,682 | 104,942 | Shares | Defined | 2023-08-15 | |
| 2023-03-31 | $78,719 | 74,265 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $93,991 | 61,837 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $316,527 | 149,306 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $200,587 | 149,693 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $236,882 | 112,267 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $613,457 | 165,353 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $2,404,065 | 481,777 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $2,553,406 | 391,627 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $2,435,634 | 353,503 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $2,416,705 | 236,932 | Shares | Defined | 2021-02-09 | |
| 2020-09-30 | $785,360 | 224,389 | Shares | Defined | 2020-11-05 | |
| 2020-06-30 | $1,338,480 | 268,233 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $543,815 | 159,946 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||